Insight - Innovation - Access - Engagement - Partnering
The global partnering and investment summit for global leaders and innovators in CNS neurosciences and psychiatric drug discovery, development, platforms and technologies.
Convened by-invitation, Bio-Neuroscience is a high level, boutique gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups crucial to the discovery, development and market launch of novel therapeutics and breakthrough platforms and technologies.
High level access, serious, sustained engagement, discussion and networking with key stakeholders. Sharing models, lessons learned, solutions, ways forward and best practices. A truly curated and unique summit to facilitate business and accelerate innovation.
We are honored by the support of our advisory board.
Meet them in person at the summit.
Executive Director, F-Prime Biomedical Research Initiative
Venture Partner - SV Health Investors, CEO - LoQus23 Therapeutics
Managing Director - Dolby Family Ventures
Global Head Translational Medicine CNS & Emerging Areas - Boehringer Ingelheim
Chief Executive Officer - Muna Therapeutics
Juan Carlos Lopez
Managing Director, Research Grants - RTW Charitable Foundation
Chairperson, Monument Therapeutics
Pieter van Bokhoven
Chief Scientific Officer - Amsterdam Neuroscience IAO - VUMC
Andrea Soto Padilla, M.D. PhD
Business Development - Amsterdam UMC
CEO - EBRAINS & Director Generał - Human Brain Projec
Christian J. Suojanen
Founder & CEO - Broadreach Global, Member of the Board - European Brain Foundation
Two days of sustained, interactive discussion, networking and partnering with:
Senior industry leaders from pharma, large biotech and healthcare companies. Heads of therapeutic area, R&D, clinical development, biological sciences, M&A, scouting, business development & licensing.
Key Opinion Leaders
Key Opinion Leaders from all stakeholder groups crucial to the successful development, approval and market launch of novel CNS neuroscience and psychiatric therapeutics, platforms and technologies.
Founders & CEOs
From startup and growth companies at the cutting edge of the future of CNS neuroscience and psychiatric drug discovery, development, advanced therapies, platforms and technologies.
Government & NGOs
Public agencies, funding bodies, foundations, societies, associations, patient organizations & NGOs in CNS neurosciences and psychiatry.
In CNS neuroscience and psychiatric drug development, platforms and technologies.
VC and corporate venture, private equity, family offices, angels & HNW.
A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants.
GET IN TOUCH
Reach us here if you like to
Nominate a speaker
Apply to present your company or technology
Enquire about sponsorship & exhibition opportunities
Be the first to know
Subscribe and be among the first to receive all Broadreach Global updates, announcements and invitations.
Please make sure to double check your email address.